☰

Ritwik Ghosh, Ph.D.

Affiliations: 
2007 Vanderbilt University, Nashville, TN 
Area:
Molecular Biology
Google:
"Ritwik Ghosh"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Susan Kasper grad student 2007 Vanderbilt
 (Stathmin mediated tumor progression through androgens and TGFbeta signaling.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chakrabarty A, Bhola NE, Sutton C, et al. (2013) Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors. Cancer Research. 73: 1190-200
Williams K, Ghosh R, Giridhar PV, et al. (2012) Inhibition of stathmin1 accelerates the metastatic process. Cancer Research. 72: 5407-17
Ghosh R, Narasanna A, Chakrabarty A, et al. (2012) Abstract 3: HER2 gene-amplified human breast cancer cells harboring a gatekeeper T768M mutation in HER2 overexpress EGFR ligands and are sensitive to dual therapeutic blockade of EGFR and HER2 Cancer Research. 72: 3-3
Ghosh R, Narasanna A, Wang SE, et al. (2011) Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers. Cancer Research. 71: 1871-82
Rexer BN, Ghosh R, Arteaga CL. (2009) Inhibition of PI3K and MEK: it is all about combinations and biomarkers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4518-20
Ghosh R, Narasanna A, Gonazalez-Angulo A, et al. (2009) Differential Signaling by ErbB Receptor (HER) Dimers: Implications for Response to Anti-HER2 Therapies in Breast Cancer. Cancer Research. 69: 705-705
Tillman JE, Yuan J, Gu G, et al. (2007) DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells. Cancer Research. 67: 4630-7
Ghosh R, Gu G, Tillman E, et al. (2007) Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. The Prostate. 67: 1038-52
See more...